<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font30">the </span>
   <span class="font19">with </span>
   <span class="font18">for </span>
   <span class="font17">COVID- </span>
   <span class="font16">patients </span>
   <span class="font14">[]. </span>
   <span class="font14">are </span>
   <span class="font12">from </span>
   <span class="font12">The </span>
   <span class="font12">have </span>
   <span class="font12">that </span>
   <span class="font12">has </span>
   <span class="font12">this </span>
   <span class="font12">treatment </span>
   <span class="font12">been </span>
   <span class="font12">clinical </span>
   <span class="font12">disease </span>
   <span class="font11">not </span>
   <span class="font11">infection </span>
   <span class="font11">respiratory </span>
   <span class="font11">risk </span>
   <span class="font11">should </span>
   <span class="font11">severe </span>
   <span class="font11">{background </span>
   <span class="font11">therapy </span>
   <span class="font11">was </span>
   <span class="font11">used </span>
   <span class="font11">may </span>
   <span class="font11">there </span>
   <span class="font11">use </span>
   <span class="font11">who </span>
   <span class="font11">coronavirus </span>
   <span class="font11">margin </span>
   <span class="font11">which </span>
   <span class="font11">virus </span>
   <span class="font11">were </span>
   <span class="font11">{border-style </span>
   <span class="font11">COVID-. </span>
   <span class="font11">can </span>
   <span class="font11">increased </span>
   <span class="font11">viral </span>
   <span class="font11">dialysis </span>
   <span class="font11">px;} </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">could </span>
   <span class="font10">more </span>
   <span class="font10">plasma </span>
   <span class="font10">reported </span>
   <span class="font10">these </span>
   <span class="font10">also </span>
   <span class="font10">high </span>
   <span class="font10">management </span>
   <span class="font10">However, </span>
   <span class="font10">data </span>
   <span class="font10">dose </span>
   <span class="font10">evidence </span>
   <span class="font10">mortality </span>
   <span class="font10">most </span>
   <span class="font10">studies </span>
   <span class="font10">This </span>
   <span class="font10">acute </span>
   <span class="font10">but </span>
   <span class="font10">cytokine </span>
   <span class="font10">drugs </span>
   <span class="font10">such </span>
   <span class="font10">than </span>
   <span class="font10">due </span>
   <span class="font10">effective </span>
   <span class="font10">effects </span>
   <span class="font10">lung </span>
   <span class="font10">medications </span>
   <span class="font10">other </span>
   <span class="font10">study </span>
   <span class="font10">syndrome </span>
   <span class="font10">against </span>
   <span class="font10">being </span>
   <span class="font10">case </span>
   <span class="font10">different </span>
   <span class="font10">general </span>
   <span class="font10">healthcare </span>
   <span class="font10">patients. </span>
   <span class="font10">transmission </span>
   <span class="font10">well </span>
   <span class="font10">will </span>
   <span class="font10">HIV </span>
   <span class="font10">agents </span>
   <span class="font10">any </span>
   <span class="font10">associated </span>
   <span class="font10">chronic </span>
   <span class="font10">critically </span>
   <span class="font10">ill </span>
   <span class="font10">patients, </span>
   <span class="font10">potential </span>
   <span class="font10">recommended </span>
   <span class="font10">through </span>
   <span class="font10">Patients </span>
   <span class="font10">There </span>
   <span class="font10">blood </span>
   <span class="font10">care </span>
   <span class="font10">immunosuppressive </span>
   <span class="font10">pandemic </span>
   <span class="font10">published </span>
   <span class="font10">review </span>
   <span class="font10">series </span>
   <span class="font10">significant </span>
   <span class="font10">testing </span>
   <span class="font10">trials </span>
   <span class="font10">COVID-, </span>
   <span class="font10">These </span>
   <span class="font10">available </span>
   <span class="font10">cases </span>
   <span class="font10">cons </span>
   <span class="font10">had </span>
   <span class="font10">higher </span>
   <span class="font10">kidney </span>
   <span class="font10">low </span>
   <span class="font10">need </span>
   <span class="font10">novel </span>
   <span class="font10">people </span>
   <span class="font10">possible </span>
   <span class="font10">response </span>
   <span class="font10">results </span>
   <span class="font10">symptoms </span>
   <span class="font10">transplant </span>
   <span class="font10">Proposed </span>
   <span class="font10">Pros </span>
   <span class="font10">active </span>
   <span class="font10">all </span>
   <span class="font10">cell </span>
   <span class="font10">convalescent </span>
   <span class="font10">daily </span>
   <span class="font10">days </span>
   <span class="font10">during </span>
   <span class="font10">economic </span>
   <span class="font10">however, </span>
   <span class="font10">human </span>
   <span class="font10">including </span>
   <span class="font10">infections </span>
   <span class="font10">px; </span>
   <span class="font10">received </span>
   <span class="font10">suggested </span>
   <span class="font10">support </span>
   <span class="font10">they </span>
   <span class="font10">treated </span>
   <span class="font10">type </span>
   <span class="font10">ventilation </span>
   <span class="font10">when </span>
   <span class="font10">{font-family </span>
   <span class="font10">(e.g., </span>
   <span class="font10">Accessed </span>
   <span class="font10">IL- </span>
   <span class="font10">MOA </span>
   <span class="font10">RNA </span>
   <span class="font10">SARS-CoV- </span>
   <span class="font10">antiviral </span>
   <span class="font10">combination </span>
   <span class="font10">continue </span>
   <span class="font10">control </span>
   <span class="font10">costs </span>
   <span class="font10">early </span>
   <span class="font10">effect </span>
   <span class="font10">experimental </span>
   <span class="font10">failure </span>
   <span class="font10">font-size </span>
   <span class="font10">health </span>
   <span class="font10">immune </span>
   <span class="font10">infectious </span>
   <span class="font10">influenza </span>
   <span class="font10">inhibitors </span>
   <span class="font10">levels </span>
   <span class="font10">pregnant </span>
   <span class="font10">receptor </span>
   <span class="font10">related </span>
   <span class="font10">several </span>
   <span class="font10">shown </span>
   <span class="font10">some </span>
   <span class="font10">storm </span>
   <span class="font10">their </span>
   <span class="font10">American </span>
   <span class="font10">Clin </span>
   <span class="font10">Disease </span>
   <span class="font10">Health </span>
   <span class="font10">IFN </span>
   <span class="font10">Infect </span>
   <span class="font10">World </span>
   <span class="font10">alveolar </span>
   <span class="font10">antibodies </span>
   <span class="font10">approach </span>
   <span class="font10">article </span>
   <span class="font10">bacterial </span>
   <span class="font10">coagulation </span>
   <span class="font10">common </span>
   <span class="font10">commonly </span>
   <span class="font10">compared </span>
   <span class="font10">decreased </span>
   <span class="font10">described </span>
   <span class="font10">double; </span>
   <span class="font10">drug </span>
   <span class="font10">especially </span>
   <span class="font10">fever </span>
   <span class="font10">first </span>
   <span class="font10">global </span>
   <span class="font10">guidelines </span>
   <span class="font10">hospitalized </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">immunosuppression </span>
   <span class="font10">infection, </span>
   <span class="font10">injury </span>
   <span class="font10">less </span>
   <span class="font10">lopinavir/ritonavir </span>
   <span class="font10">lower </span>
   <span class="font10">medical </span>
   <span class="font10">might </span>
   <span class="font10">outcomes </span>
   <span class="font10">pneumonia </span>
   <span class="font10">population. </span>
   <span class="font10">positive </span>
   <span class="font10">proven </span>
   <span class="font10">pulmonary </span>
   <span class="font10">receiving </span>
   <span class="font10">replication </span>
   <span class="font10">social </span>
   <span class="font10">solid-organ </span>
   <span class="font10">therapies </span>
   <span class="font10">two </span>
   <span class="font10">unless </span>
   <span class="font10">Although </span>
   <span class="font10">Care </span>
   <span class="font10">Centers </span>
   <span class="font10">Control </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">ECMO </span>
   <span class="font10">FDA </span>
   <span class="font10">MERS </span>
   <span class="font10">Med </span>
   <span class="font10">Medical </span>
   <span class="font10">PEEP </span>
   <span class="font10">SARS </span>
   <span class="font10">activity </span>
   <span class="font10">arthritis </span>
   <span class="font10">authors </span>
   <span class="font10">avoid </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">caused </span>
   <span class="font10">cells </span>
   <span class="font10">cohort </span>
   <span class="font10">complications </span>
   <span class="font10">course </span>
   <span class="font10">days, </span>
   <span class="font10">dosing </span>
   <span class="font10">elevated </span>
   <span class="font10">far </span>
   <span class="font10">found </span>
   <span class="font10">glucocorticoids </span>
   <span class="font10">guidance </span>
   <span class="font10">histamine </span>
   <span class="font10">home </span>
   <span class="font10">immunity </span>
   <span class="font10">infected </span>
   <span class="font10">inflammatory </span>
   <span class="font10">initial </span>
   <span class="font10">into </span>
   <span class="font10">its </span>
   <span class="font10">many </span>
   <span class="font10">much </span>
   <span class="font10">must </span>
   <span class="font10">organ </span>
   <span class="font10">oxygenation </span>
   <span class="font10">pandemic, </span>
   <span class="font10">patient </span>
   <span class="font10">pressure </span>
   <span class="font10">randomized </span>
   <span class="font10">rate </span>
   <span class="font10">recent </span>
   <span class="font10">recently </span>
   <span class="font10">regarding </span>
   <span class="font10">renal </span>
   <span class="font10">reports </span>
   <span class="font10">resources </span>
   <span class="font10">same </span>
   <span class="font10">significantly </span>
   <span class="font10">solid; </span>
   <span class="font10">systemic </span>
   <span class="font10">trial </span>
   <span class="font10">using </span>
   <span class="font10">vitro </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(.%) </span>
   <span class="font10">AKI </span>
   <span class="font10">All </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Center </span>
   <span class="font10">Clinical </span>
   <span class="font10">Data </span>
   <span class="font10">Drug </span>
   <span class="font10">ESKD </span>
   <span class="font10">Ebola </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">Food </span>
   <span class="font10">HRA </span>
   <span class="font10">Hong </span>
   <span class="font10">June </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Management </span>
   <span class="font10">May </span>
   <span class="font10">Some </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">action </span>
   <span class="font10">adverse </span>
   <span class="font10">al.Clinical </span>
   <span class="font10">among </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">antibody </span>
   <span class="font10">appropriate </span>
   <span class="font10">article. </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">azithromycin </span>
   <span class="font10">back </span>
   <span class="font10">benefit </span>
   <span class="font10">bold </span>
   <span class="font10">clearance </span>
   <span class="font10">courier; </span>
   <span class="font10">day </span>
   <span class="font10">death </span>
   <span class="font10">deaths </span>
   <span class="font10">distancing </span>
   <span class="font10">distress </span>
   <span class="font10">edema </span>
   <span class="font10">efficacy </span>
   <span class="font10">em; </span>
   <span class="font10">emerging </span>
   <span class="font10">even </span>
   <span class="font10">features </span>
   <span class="font10">five </span>
   <span class="font10">followed </span>
   <span class="font10">future </span>
   <span class="font10">group </span>
   <span class="font10">hospital </span>
   <span class="font10">illness </span>
   <span class="font10">impact </span>
   <span class="font10">individual </span>
   <span class="font10">infection. </span>
   <span class="font10">investigated </span>
   <span class="font10">isolation </span>
   <span class="font10">late </span>
   <span class="font10">like </span>
   <span class="font10">limited </span>
   <span class="font10">mechanism </span>
   <span class="font10">members </span>
   <span class="font10">membrane </span>
   <span class="font10">mortality. </span>
   <span class="font10">multi-organ </span>
   <span class="font10">multiple </span>
   <span class="font10">new </span>
   <span class="font10">observational </span>
   <span class="font10">ongoing </span>
   <span class="font10">over </span>
   <span class="font10">oxygen </span>
   <span class="font10">preferred </span>
   <span class="font10">preliminary </span>
   <span class="font10">progression </span>
   <span class="font10">provide </span>
   <span class="font10">provided </span>
   <span class="font10">pt;} </span>
   <span class="font10">public </span>
   <span class="font10">purification </span>
   <span class="font10">reduced </span>
   <span class="font10">refractory </span>
   <span class="font10">requiring </span>
   <span class="font10">retrospective </span>
   <span class="font10">routine </span>
   <span class="font10">septic </span>
   <span class="font10">severely </span>
   <span class="font10">severity </span>
   <span class="font10">side </span>
   <span class="font10">specific </span>
   <span class="font10">spread </span>
   <span class="font10">systematic </span>
   <span class="font10">team </span>
   <span class="font10">tested </span>
   <span class="font10">them </span>
   <span class="font10">therapeutic </span>
   <span class="font10">tidal </span>
   <span class="font10">transplanted </span>
   <span class="font10">treat </span>
   <span class="font10">under </span>
   <span class="font10">unit </span>
   <span class="font10">used, </span>
   <span class="font10">vaccine </span>
   <span class="font10">various </span>
   <span class="font10">vascular </span>
   <span class="font10">ventilator </span>
   <span class="font10">while </span>
   <span class="font10">without </span>
   <span class="font10">worsening </span>
  </p>
 </body>
</html>
